Anticipating Triumph: NTRK Fusion Gene Positive Tumors Market Soars to US$230 Million in 2033
The NTRK fusion gene positive advanced solid tumors market emerges as a beacon of optimism. With a projected Compound Annual Growth Rate (CAGR) of 5.9% and an anticipated value soaring to US$ 230 Million by 2033, this market is not just a statistic; it’s a testament to progress. In a world where cancer remains a…